LEADER 00784nam0-22002891i-450- 001 990000883700403321 005 20001010 035 $a000088370 035 $aFED01000088370 035 $a(Aleph)000088370FED01 035 $a000088370 100 $a20001010d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aLectures on the Theory of Elliptic Function 210 $aNew York$cDover Publications$d1958. 215 $ap.498$dill.$dcm 20 610 0 $aMatematica 700 1$aHancock,$bHarris$043234 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990000883700403321 952 $a03 M.0,24$b1186$fIINTC 959 $aIINTC 996 $aLectures on the Theory of Elliptic Function$9356079 997 $aUNINA DB $aING01 LEADER 03868nam 22007455 450 001 9910300214003321 005 20251116140310.0 010 $a4-431-54487-9 024 7 $a10.1007/978-4-431-54487-6 035 $a(CKB)3710000000311825 035 $a(EBL)1966183 035 $a(OCoLC)908085244 035 $a(SSID)ssj0001408195 035 $a(PQKBManifestationID)11818665 035 $a(PQKBTitleCode)TC0001408195 035 $a(PQKBWorkID)11346220 035 $a(PQKB)10892736 035 $a(DE-He213)978-4-431-54487-6 035 $a(MiAaPQ)EBC1966183 035 $a(PPN)183147154 035 $a(EXLCZ)993710000000311825 100 $a20141203d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aBehçet's Disease $eFrom Genetics to Therapies /$fedited by Yoshiaki Ishigatsubo 205 $a1st ed. 2015. 210 1$aTokyo :$cSpringer Japan :$cImprint: Springer,$d2015. 215 $a1 online resource (183 p.) 300 $aDescription based upon print version of record. 311 08$a4-431-54486-0 320 $aIncludes bibliographical references and index. 327 $a1. Overview -- 2. The Immunopathology of Behcet?s Disease -- 3. Genetics -- 4. Ocular Involvement -- 5. Vascular Involvement of Behçet?s Disease -- 6. Neurological Involvement -- 7. Gastrointestinal Involvement -- 8. Mucocutaneous Manifestations -- 9. Perspective . 330 $aThis book, besides reviewing basic and clinical aspects of Behçet's disease, covers the latest findings, including genetic studies and treatment with biologics for the disease. Although the cause of Behçet's disease is still unknown, it is well known that genetic factors, such as HLA-B51, are involved in its development. Recently, novel susceptibility loci including IL10, IL23R-IL12RB2, and endoplasmic reticulum aminopeptidase 1 have been identified, providing new insights into the pathogenesis of the disease. In addition to basic research, the beneficial efficacy of anti-TNF-alpha monoclonal antibodies has also been suggested for not only uveitis associated with the disease but also other subtypes of the disease such as entero-, vasculo-, and neuro- Behçet's disease. Behçet's Disease:  From Genetics to Therapies  provides essential information both for basic researchers working in the fields of immunology, inflammation, and genetics, and for clinical physicians who are interested in Behçet's disease, such as ophthalmologists, rheumatologists, dermatologists, gastroenterologists, neurologists, and vascular surgeons. 606 $aRheumatology 606 $aAllergy 606 $aDermatology 606 $aOphthalmology 606 $aGastroenterology 606 $aRheumatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33170 606 $aAllergology$3https://scigraph.springernature.com/ontologies/product-market-codes/H11009 606 $aDermatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H1900X 606 $aOphthalmology$3https://scigraph.springernature.com/ontologies/product-market-codes/H44004 606 $aGastroenterology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33061 615 0$aRheumatology. 615 0$aAllergy. 615 0$aDermatology. 615 0$aOphthalmology. 615 0$aGastroenterology. 615 14$aRheumatology. 615 24$aAllergology. 615 24$aDermatology. 615 24$aOphthalmology. 615 24$aGastroenterology. 676 $a610 676 $a614.5993 676 $a616.33 676 $a616.5 702 $aIshigatsubo$b Yoshiaki$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300214003321 996 $aBehçet's Disease$91760465 997 $aUNINA